Medicaid expansion leads to increase in early-stage cancer diagnoses

BLOOMINGTON, Ind. — The Affordable Care Act led to an increase in the number of cancer diagnoses — particularly those at early stages — in states where Medicaid was expanded, according to research from Indiana University.

The research, published in the American Journal of Public Health, suggests that public health insurance may increase cancer detection, which can lead to fewer cancer deaths and better outcomes for patients.

Read full article here.

IU-CTO is now the Office of Clinical Research

We are delighted to announce that our office is changing its name from the Indiana University Clinical Trials Office to the Office of Clinical Research, effective September 1, 2017.

This name change reflects our commitment to expand our support for the entire Research Community.

We look forward to serving you under our new banner.

The Office of Clinical Research (OCR) was created to serve as a hub for Clinical Research connecting Indiana University, its strategic partner IU Health, and its other partners across the research community. Efforts are underway to enhance the clinical research engagement process, streamline contracting for industry sponsored clinical research, optimize budgeting and study facilitation processes, create an optimal environment and workforce for clinical research, increase clinical research participation and the number of clinical research studies across the research community, and to engage key stakeholders to enhance our partnerships. The Office of Clinical Research will continue to develop community-wide approaches to enhance the efficiency, effectiveness, and quality of Clinical Research conducted throughout the entire state of Indiana.

For any questions about our office, or any of our services, we encourage you to please contact our office at our main inbox:

Clinical Research Coordinator Tools Now Available

As a result of the responses to the Research Survey several weeks ago, we are now able to share examples of study visit checklists used by research coordinators across the research community. The documents are now posted in the Private Documents section of the Office of Clinical Research (OCR) website. There are a variety of styles of checklists available. All of the documents are editable, making it possible for you to modify them to suit your needs. By sharing examples across the research community, our goal is to reduce the length of time spent by coordinators in creating these documents. Hopefully, this will help!

You can find the documents in the Private Documents section of our website. To navigate to the documents, take the following steps: On the main page, click to log in. Log in through the usual CAS method. Once you’re logged in, look at the bottom right corner of the page and click on Private Documents. Once you’ve entered Private Documents, click on the folder called Coordinator Resources to locate the shared checklist examples. Should you have trouble locating the documents, or gaining access to the Private Documents section of the website, please contact the Office of Clinical Research by email at for assistance.

Naga Chalasani named IU School of Medicine associate dean for clinical research

June 30, 2017

INDIANAPOLIS – Indiana University School of Medicine will enhance research that explores whether medical treatments or therapies are effective in humans with the appointment of a new associate dean for clinical research, Naga Chalasani, MD, an international leader in gastroenterology and hepatology research with extensive experience in patient-oriented research, clinical trials and drug development.

As the associate dean for clinical research, Dr. Chalasani will help IU School of Medicine grow the number of researchers engaged in clinical trials, encourage faculty participation and leadership in industry-sponsored clinical trials, promote the clinical trials resources of the IU Clinical Trials Office (CTO) and the Indiana Clinical and Translational Sciences Institute (CTSI), liaise with hospital partners and pharmaceutical companies, and implement best practices to improve clinical research across the school.

The new position will be an addition to Dr. Chalasani’s current roles as David W. Crabb Professor of Medicine at IU School of Medicine, division chief of gastroenterology and hepatology in the Department of Medicine and adjunct professor of cellular and integrative physiology. He joined IU School of Medicine in 1997 and became division chief in 2007.

Dr. Chalasani is internationally known for his expertise in nonalcoholic fatty liver disease and drug-induced liver injury, and he is the lead author for the multisociety practice guideline on the diagnosis and management of nonalcoholic fatty liver disease, as well as the American College of Gastroenterology practice guideline on the diagnosis and management of drug-induced liver injury.

Dr. Chalasani has also consulted on drug development activities and regulatory matters related to fatty liver disease and drug safety for pharmaceutical companies and the United States Food and Drug Administration. He currently serves as the academic chair for the International Consortium for Innovation and Quality in Pharmaceutical Development’s initiative on drug-induced liver injury.

Anantha Shekhar, MD, PhD, IU associate vice president of research for university clinical affairs and IU School of Medicine executive associate dean for research affairs, said Dr. Chalasani’s scientific expertise, experience and industry connections make him an ideal fit for the position of associate dean for clinical research.

“Naga brings a deep knowledge of our institution and our hospital partners to this position, with proven experience in clinical trials, corporate relationships and corresponding regulatory issues,” Dr. Shekhar said. “I look forward to working with him to advance this extremely important area of research at IU School of Medicine.”

Dr. Chalasani said he is excited to serve in this new role and believes the university and school are well positioned to succeed in their goal to enhance clinical research.

“IU possesses an unprecedented opportunity to dramatically increase our patient-oriented research portfolio because of our extensive clinical footprint throughout the state of Indiana and very large physician workforce through key hospital partners, as well as our growing clinical trials infrastructure through our CTO and the Indiana CTSI,” Dr. Chalasani said. “I believe a robust clinical research portfolio is essential for the school to fulfill its mission of dramatically improving the health and well-being of the residents of Indiana.”

Dr. Chalasani will begin his new duties on July 1, 2017.


Click to view the full article